loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 20005 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 NICARDIPINE HYDROCHLORIDE (3)

filter

01 CHIESI (3)

filter

01 CAPSULE, EXTENDED RELEASE;ORAL (3)

filter

01 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)

02 45MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)

03 60MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)

filter

01 USA (3)

URL Supplier Web Content
CAPSULE, EXTENDED RELE...
45MG **Federal Registe...
CARDENE SR
USA
20005
1992-02-21
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
CAPSULE, EXTENDED RELE...
60MG **Federal Registe...
CARDENE SR
USA
20005
1992-02-21
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
CAPSULE, EXTENDED RELE...
30MG **Federal Registe...
CARDENE SR
USA
20005
1992-02-21
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 20005

Looking for CTD TGA MCC DOSSIER APPLICATION 20005 3

19

CHIESI USA INC, based in U.S.A, is a pharmaceutical company.

One of their notable products is NICARDIPINE HYDROCHLORIDE, with a corresponding application number 20005 and regulatory information .

proudly manufactured in the

approval since 1992-02-21

CHIESI USA INC's CARDENE SR CAPSULE, EXTENDED RELEASE;ORAL, medication with 45MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of NICARDIPINE HYDROCHLORIDE.

18

CHIESI USA INC, based in U.S.A, is a pharmaceutical company.

One of their notable products is NICARDIPINE HYDROCHLORIDE, with a corresponding application number 20005 and regulatory information .

proudly manufactured in the

approval since 1992-02-21

CHIESI USA INC's CARDENE SR CAPSULE, EXTENDED RELEASE;ORAL, medication with 60MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of NICARDIPINE HYDROCHLORIDE.

17

CHIESI USA INC, based in U.S.A, is a pharmaceutical company.

One of their notable products is NICARDIPINE HYDROCHLORIDE, with a corresponding application number 20005 and regulatory information .

proudly manufactured in the

approval since 1992-02-21

CHIESI USA INC's CARDENE SR CAPSULE, EXTENDED RELEASE;ORAL, medication with 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of NICARDIPINE HYDROCHLORIDE.

Post Enquiry
POST ENQUIRY